A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD

Status:
Completed

Trial end date:
2002-12-01

Target enrollment:

Participant gender:

To determine if ABX-IL8 will improve shortness of breath.

Phase 2

Abgenix